OKI-219

N/A

Report date: 2024/01/09 10:39:27
NME

Base Information

Drug NameOKI-219
Drug Alias NameOKI-219
ClassificationSmall molecules
Mechanisms of ActionPhosphoinositide 3-kinase alpha H1047R inhibitorsPhosphotransferases inhibitors
TargetsPhosphoinositide 3-kinase alpha H1047RPhosphotransferases
Therapy Area/IndicationsSolid tumoursBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOnkure Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnkure Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A